Iaslc, 폐암 전문의 대상으로 분자 테스트에 대한 글로벌 서베이 실시
12 juil. 2018 16h11 HE
|
IASLC
미국 덴버, July 13, 2018 (GLOBE NEWSWIRE) -- 국제폐암연구협회(IASLC)가 폐암 환자에 대한 분자 테스트 관련 종사자들을 대상으로 글로벌 서베이를 실시한다. 이번 서베이는 베스트 프랙티스가 시행되고 있는지 평가하고 궁극적으로는 글로벌 분자 테스트 가이드라인을 개발하기 위해 설계되었다. IASLC Global Survey on...
IASLC เชิญชวนผู้เชี่ยวชาญเกี่ยวกับโรคมะเร็งปอดให้ทำแบบสำรวจเกี่ยวกับการทดสอบด้านโมเลกุล
12 juil. 2018 16h11 HE
|
IASLC
DENVER, July 13, 2018 (GLOBE NEWSWIRE) -- สมาคมระหว่างประเทศเพื่อการศึกษาโรคมะเร็งปอด (IASLC)...
IASLC Invites Lung Cancer Professionals to Take Global Survey on Molecular Testing
11 juil. 2018 14h46 HE
|
IASLC
DENVER, July 11, 2018 (GLOBE NEWSWIRE) -- The International Association for the Study of Lung Cancer (IASLC) encourages all those involved in molecular testing of lung cancer patients to participate...
Pascal Biosciences: Cannabinoids Could Play a Role in Destroying Cancer Cells -- CFN Media
03 juil. 2018 09h00 HE
|
CFN Media
SEATTLE, July 03, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced...
Alectra pedals for cancer research
11 juin 2018 14h46 HE
|
Alectra Utilities Corporation
MISSISSAUGA, Ontario, June 11, 2018 (GLOBE NEWSWIRE) -- A team of 35 Alectra employees cycled in the annual Enbridge® Ride to Conquer Cancer® on June 9 and 10, travelling more than 200 kilometres...
Karmanos Cancer Institute to begin renovations to expand services in Farmington Hills
18 mai 2018 08h10 HE
|
Barbara Ann Karmanos Cancer Institute
DETROIT, May 18, 2018 (GLOBE NEWSWIRE) -- The Barbara Ann Karmanos Cancer Institute announced today it will expand its Lawrence and Idell Weisberg Cancer Treatment Center in Farmington Hills into a...
CicloMed Announces Presentation of Preclinical Evidence for its Bladder Cancer Agent at AACR 2018 Meeting
12 avr. 2018 09h00 HE
|
CicloMed LLC
KANSAS CITY, Mo., April 12, 2018 (GLOBE NEWSWIRE) -- CicloMed LLC, a biotechnology company developing novel treatments for bladder cancer, today announced the presentation of preclinical evidence...
CrownBio Enters Strategic Partnership with Phanes Therapeutics to Accelerate Discovery and Development of Phanes’ Novel Oncology Agents
13 mars 2018 08h00 HE
|
Crown Bioscience
SAN DIEGO, March 13, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company...
Webinar to Reveal Data Supporting the Use of MuScreen™ for Preclinical Immunotherapeutic Development
27 févr. 2018 08h00 HE
|
Crown Bioscience
SAN DIEGO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company...
Cannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles; Research Team Begins Evaluating Commercialization Options
22 févr. 2018 07h39 HE
|
Cannabis Science, Inc.
IRVINE, CA, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is very pleased to report the...